15-27985172-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 4P and 20B. PM1PM5BP4_StrongBP6_Very_StrongBA1
The NM_000275.3(OCA2):c.1256G>A(p.Arg419Gln) variant causes a missense change. The variant allele was found at a frequency of 0.068 in 1,613,592 control chromosomes in the GnomAD database, including 4,410 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R419W) has been classified as Pathogenic.
Frequency
Consequence
NM_000275.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OCA2 | NM_000275.3 | c.1256G>A | p.Arg419Gln | missense_variant | 13/24 | ENST00000354638.8 | NP_000266.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OCA2 | ENST00000354638.8 | c.1256G>A | p.Arg419Gln | missense_variant | 13/24 | 1 | NM_000275.3 | ENSP00000346659 | P1 | |
OCA2 | ENST00000353809.9 | c.1184G>A | p.Arg395Gln | missense_variant | 12/23 | 1 | ENSP00000261276 |
Frequencies
GnomAD3 genomes AF: 0.0486 AC: 7402AN: 152172Hom.: 241 Cov.: 32
GnomAD3 exomes AF: 0.0469 AC: 11577AN: 246792Hom.: 345 AF XY: 0.0485 AC XY: 6492AN XY: 133732
GnomAD4 exome AF: 0.0700 AC: 102342AN: 1461302Hom.: 4169 Cov.: 35 AF XY: 0.0689 AC XY: 50090AN XY: 726900
GnomAD4 genome AF: 0.0486 AC: 7403AN: 152290Hom.: 241 Cov.: 32 AF XY: 0.0474 AC XY: 3528AN XY: 74452
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 17, 2015 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Tyrosinase-positive oculocutaneous albinism Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES Other:1
Affects, no assertion criteria provided | literature only | OMIM | Feb 01, 2008 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at